![](http://somrubioscience.com/wp-content/uploads/2023/11/B_01.jpg)
![](http://somrubioscience.com/wp-content/uploads/2023/06/2.png)
![](http://somrubioscience.com/wp-content/uploads/2023/06/1585844054769.png)
![](http://somrubioscience.com/wp-content/uploads/2023/06/4.jpg)
for precise, sensitive, and accurate measurement of biologics
Somru is actively responding to the current
coronavirus SARS-COV-2 outbreak.
Business contunity update
![](https://somrubioscience.com/wp-content/uploads/2021/08/unnamed.jpg)
Accelerating Biosimilars Development
The rise of biosimilars has provided challenges and opportunities in equal measure for biotechnology, biopharmaceutical and bioanalytical contract research organizations (CROs). Somru BioScience has developed a portfolio of reagents, tools, solutions and a knowledge database that will enable companies to capitalize on biosimilar opportunities. We provide comprehensive expertise and solutions to reduce both the time and cost of your biosimilar development programsa
![](https://somrubioscience.com/wp-content/uploads/2021/08/images-10.jpg)
How similar is your biosimilars?
Somru BioScience has developed an intelli.b™ platform for comparability testing of Biologics/ Biosimilars at molecular level that meets the intent of the FDA guidance for fingerprint-like analysis.
![](https://somrubioscience.com/wp-content/uploads/2021/08/download-1.jpg)
Immunogenicity ELISA
Somru BioScience offers high quality, sensitive and robust off-the-shelf ELISA kits for the measurement of anti-drug antibodies (i.e. both anti-innovator and anti-biosimilar) in biological matrices.
![](https://somrubioscience.com/wp-content/uploads/2021/08/images-9.jpg)
Biomarker Testing Solutions
Biomarkers have become an integral part of the decision-making process not only in the personalized drug development process, but also in biosimilar and biobetter drug development.
New Products
Products
-
SBFY56: Anti-PlGF
Rated 0 out of 5$0.00 -
Ab49: Anti-VEGF
Rated 0 out of 5$0.00 -
Ab11: Anti-VEGF
Rated 0 out of 5$0.00 -
Ab27: Anti-VEGF
Rated 0 out of 5$0.00 -
Denosumab PK
Rated 0 out of 5$399.00